Whether it’s the slow unraveling of a long-term relationship or an out-of-the-blue ghosting scenario, breakups hurt and they ...

Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...

FDA approves suzetrigine, a non-opioid painkiller that blocks sodium channels, offering potent relief without addiction risks.

The Phase IIa results continue a surge of momentum in a treatment space that last week saw the approval of Vertex’s Journavx ...

President Donald Trump insists tariffs on our closest neighbors are needed to “protect Americans," but he conceded Sunday that they might also cause “some pain." ...

Vaginismus, an under-studied sexual dysfunction, involves involuntary spasms of pelvic muscles that can be due to physical ...

Scratching isn’t just a bad habit — it’s an immune defense mechanism. While it fuels inflammation, it also helps fight ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

The novel formulation of rizatriptan and meloxicam (Symbravo, Axome Therapeutics) is for the acute treatment of migraine with ...

The approval of Axsome Therapeutics’ Symbravo for migraine with or without aura came alongside the greenlight for Vertex's ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids.